NeuroSense Therapeutics (NRSN) Stock Chart & Stock Price History → They say it’s ‘unstoppable’ – How I made 43,509% (From Investing Daily) (Ad) Free NRSN Stock Alerts $1.23 -0.03 (-2.38%) (As of 04/26/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media NeuroSense Therapeutics Stock Price Performance5 Day Performance-8.89%1 Month Performance-28.90%3 Month Performance+20.59%6 Month Performance+177.84%Year-To-Date Performance+56.69%1 Year Performance-35.26% Receive NRSN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NeuroSense Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Investing DailyThey say it’s ‘unstoppable’ – How I made 43,509% Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.Click here now for the full story. NRSN Stock Chart for Saturday, April, 27, 2024 NRSN Chart by TradingView NeuroSense Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/26/2024$1.26$1.23-2.38%$1.29$1.1742,068 shs$16.81 million04/25/2024$1.34$1.26-5.97%$1.32$1.21139,169 shs$17.22 million04/24/2024$1.36$1.34-1.47%$1.50$1.30132,898 shs$18.32 million04/23/2024$1.35$1.36+0.74%$1.37$1.3079,099 shs$18.59 million04/22/2024$1.42$1.35-4.93%$1.44$1.11355,849 shs$18.45 million04/19/2024$1.52$1.42-6.58%$1.53$1.30121,555 shs$19.41 million Get the Latest News and Ratings for NRSN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NeuroSense Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/18/2024$1.60$1.52-5.00%$1.62$1.45267,082 shs$20.77 million04/17/2024$1.65$1.60-3.03%$1.64$1.5672,130 shs$21.87 million04/16/2024$1.53$1.65+7.84%$1.73$1.52115,582 shs$22.56 million04/15/2024$1.60$1.53-4.38%$1.66$1.5272,243 shs$20.92 million04/12/2024$1.68$1.60-4.76%$1.81$1.53159,672 shs$21.87 million04/11/2024$1.66$1.68+1.20%$1.78$1.51277,203 shs$22.97 million04/10/2024$1.72$1.66-3.49%$1.69$1.55148,488 shs$22.69 million04/09/2024$1.74$1.72-1.15%$1.93$1.61177,040 shs$23.51 million04/08/2024$1.70$1.74+2.35%$1.81$1.67163,301 shs$23.79 million04/05/2024$2.06$1.70-17.48%$2.25$1.50918,364 shs$23.24 million04/04/2024$2.05$2.06+0.49%$2.25$1.97250,683 shs$28.15 million04/03/2024$1.84$2.05+11.41%$2.13$1.81317,747 shs$28.02 million04/02/2024$1.83$1.84+0.55%$1.84$1.7463,128 shs$25.15 million04/01/2024$1.82$1.83+0.55%$1.86$1.7680,636 shs$25.02 million03/29/2024$1.82$1.82$1.85$1.73113,890 shs$24.87 million03/28/2024$1.73$1.82+5.20%$1.85$1.73113,446 shs$24.88 million03/27/2024$1.70$1.73+1.76%$1.81$1.6982,346 shs$23.65 million03/26/2024$1.82$1.70-6.59%$1.82$1.45133,684 shs$23.24 million03/25/2024$1.76$1.82+3.41%$1.83$1.7355,450 shs$24.88 million03/22/2024$1.81$1.76-2.76%$1.89$1.72184,016 shs$24.06 million03/21/2024$1.67$1.81+8.38%$1.85$1.75210,956 shs$24.74 million03/20/2024$1.48$1.67+12.84%$1.68$1.48157,259 shs$22.83 million03/19/2024$1.41$1.48+5.34%$1.58$1.40309,265 shs$20.23 million03/18/2024$1.38$1.41+1.81%$1.43$1.32195,120 shs$19.21 million03/15/2024$1.39$1.38-0.72%$1.47$1.31117,198 shs$18.87 million03/14/2024$1.64$1.39-15.24%$1.73$1.35256,929 shs$19.00 million03/13/2024$1.57$1.64+4.46%$1.69$1.54158,789 shs$22.42 million03/12/2024$1.67$1.57-5.99%$1.67$1.51195,565 shs$21.46 million03/11/2024$1.79$1.67-6.70%$1.84$1.60205,761 shs$22.83 million03/08/2024$2.01$1.79-10.95%$2.09$1.72468,188 shs$24.47 million03/07/2024$2.08$2.01-3.37%$2.10$1.99145,676 shs$27.48 million03/06/2024$2.03$2.08+2.46%$2.13$1.98307,970 shs$28.43 million03/05/2024$2.11$2.03-3.79%$2.08$1.90375,473 shs$27.74 million03/04/2024$2.05$2.11+2.93%$2.29$1.96478,678 shs$28.84 millionThey say it’s ‘unstoppable’ – How I made 43,509% (Ad)Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.Click here now for the full story.03/01/2024$1.77$2.05+15.82%$2.33$1.771.28 million shs$28.02 million02/29/2024$1.80$1.77-1.67%$1.86$1.57492,622 shs$24.20 million02/28/2024$1.80$1.80$1.94$1.74590,415 shs$24.61 million02/27/2024$1.39$1.80+29.50%$2.20$1.502.76 million shs$24.61 million02/26/2024$1.27$1.39+9.45%$1.43$1.25369,645 shs$19.00 million02/23/2024$1.26$1.27+0.79%$1.33$1.2390,448 shs$0.0002/22/2024$1.25$1.26+0.80%$1.32$1.21144,020 shs$0.0002/21/2024$1.33$1.25-6.02%$1.32$1.152.26 million shs$0.0002/20/2024$1.37$1.33-2.92%$1.39$1.30253,533 shs$14.55 million02/19/2024$1.37$1.37$1.37$1.29128,400 shs$0.0002/16/2024$1.33$1.37+3.01%$1.37$1.29127,209 shs$0.0002/15/2024$1.38$1.33-3.62%$1.39$1.29137,543 shs$14.55 million02/14/2024$1.26$1.38+9.52%$1.40$1.26223,400 shs$0.0002/13/2024$1.28$1.26-1.56%$1.30$1.24121,250 shs$0.0002/12/2024$1.30$1.28-1.54%$1.30$1.10225,627 shs$0.0002/09/2024$1.32$1.28-3.03%$1.30$1.2689,265 shs$0.0002/08/2024$1.28$1.32+3.13%$1.33$1.26118,369 shs$0.0002/07/2024$1.28$1.28$1.29$1.1882,703 shs$0.0002/06/2024$1.25$1.28+2.40%$1.32$1.23128,234 shs$0.0002/05/2024$1.28$1.25-2.34%$1.30$1.20102,078 shs$13.68 million02/02/2024$1.30$1.28-1.16%$1.30$1.17128,254 shs$0.0002/01/2024$1.25$1.30+3.60%$1.33$1.24378,528 shs$0.0001/31/2024$1.08$1.25+15.74%$1.30$1.06475,986 shs$0.0001/30/2024$1.08$1.08+0.47%$1.13$0.94415,884 shs$0.0001/29/2024$1.02$1.08+5.39%$1.09$1.02337,674 shs$0.0001/26/2024$1.03$1.02-0.97%$1.05$0.98120,041 shs$11.16 million Related Companies: FLGC Stock Chart KALA Stock Chart HUGE Stock Chart GLTO Stock Chart TCRT Stock Chart ORGS Stock Chart BNTC Stock Chart NERV Stock Chart BIVI Stock Chart APM Stock Chart Receive NRSN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for NeuroSense Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:NRSN) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingThey say it’s ‘unstoppable’ – How I made 43,509% Investing DailyHe Is Giving Away BitcoinCrypto Swap ProfitsProtect Your Bank Account Before It’s Too LateWeiss RatingsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeuroSense Therapeutics Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.